Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-26-030614
Filing Date
2026-05-05
Accepted
2026-05-05 16:24:20
Documents
62
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ctnm-20260331.htm   iXBRL 10-Q 769516
2 EX-31.1 q1202610-qexx311.htm EX-31.1 11215
3 EX-31.2 q1202610-qexx312.htm EX-31.2 11235
4 EX-32.1 q1202610-qexx321.htm EX-32.1 5795
5 EX-32.2 q1202610-qexx322.htm EX-32.2 5791
11 ctnm-20260331_g1.jpg GRAPHIC 264562
  Complete submission text file 0001628280-26-030614.txt   5715889

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ctnm-20260331.xsd EX-101.SCH 33147
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ctnm-20260331_cal.xml EX-101.CAL 61727
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ctnm-20260331_def.xml EX-101.DEF 200991
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ctnm-20260331_lab.xml EX-101.LAB 488831
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ctnm-20260331_pre.xml EX-101.PRE 355957
66 EXTRACTED XBRL INSTANCE DOCUMENT ctnm-20260331_htm.xml XML 686214
Mailing Address 3565 GENERAL ATOMICS COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 3565 GENERAL ATOMICS COURT, SUITE 200 SAN DIEGO CA 92121 (858) 333-5280
Contineum Therapeutics, Inc. (Filer) CIK: 0001855175 (see all company filings)

EIN.: 271467257 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-42001 | Film No.: 26943636
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)